TNF and melanoma: In addition, melanoma even elicits resistance to adoptive T-cell transfer therapies through the proinflammatory cytokine tumor necrosis factor (TNF)-induced reversible dedifferentiation, hinting strategies to sustain T-cell effector functions through minimizing immune-inhibitory effects in the melanoma microenvironment 8.